
Pharma in Focus: CLIR, CGEN, GALE
ClearSign Combustion Corporation (NASDAQ:CLIR) said it agreed to sell $6.5 million of its common stock to certain institutional investors at $8.00 each, a 9% discount to Thursday’s closing price. The company will sell 812,500 shares and will use the net proceeds for research and development, protection of intellectual property, business development and marketing, and for working capital. The company designs technology to improve the efficiency … Continue reading Pharma in Focus: CLIR, CGEN, GALE